JASON TRUSTY: Open Payments
NPI 1467566463 · CHARLESTON, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,899 in 77 payments from 19 companies in 2025. Trend: 2023 $1,608 · 2024 $2,308 · 2025 $2,899
Food & beverage: $2,269Consulting: $630
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 16 | $1,155 |
| AstraZeneca Pharmaceuticals LP | 9 | $426 |
| GENZYME CORPORATION | 14 | $376 |
| Regeneron Healthcare Solutions, Inc. | 11 | $369 |
| GlaxoSmithKline, LLC. | 10 | $136 |
| Genentech, Inc. | 1 | $105 |
| CSL Behring | 2 | $58 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $50 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $31 |
| Incyte Corporation | 1 | $29 |
Products named: DUPIXENT, AIRSUPRA, XOLAIR, FASENRA, Rhapsido, NUCALA, BREZTRI, TRELEGY ELLIPTA.
Industry payments across WV — which companies pay providers there.
